Identification of gene biomarkers to predict responses to neoadjuvant chemoradiotherapy in patients with rectal cancer and pathways enrichment analysis
10.3760/cma.j.issn.1671-0274.2019.12.015
- VernacularTitle: 直肠癌新辅助放化疗疗效预测的分子标记物筛选及下游核心信号通路分析
- Author:
Xiaojie WANG
1
;
Qian YU
2
;
Pan CHI
1
;
Huiming LIN
1
;
Xingrong LU
1
;
Ying HUANG
1
;
Zongbin XU
1
;
Shenghui HUANG
1
;
Yanwu SUN
1
;
Daoxiong YE
1
Author Information
1. Department of Colorectal Surgery, Union Hospital, Fujian Medical University, Fuzhou 350001, China
2. Department of Pathology, Union Hospital, Fujian Medical University, Fuzhou 350001, China
- Publication Type:Journal Article
- Keywords:
Rectal neoplasms;
Neoadjuvant chemoradiotherapy;
Biomarkers;
Pathways
- From:
Chinese Journal of Gastrointestinal Surgery
2019;22(12):1183-1187
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To screen out the potential gene biomarkers to predict responses to neoadjuvant chemoradiotherapy (CRT) in patients with rectal cancer and to explore the main downstream pathways of resistance.
Methods:The gene expression profiles (GSE35452) of locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy from 46 specimens (24 responders, TRG 0/1, and 22 non-responders, TRG 2/3) were downloaded from the GEO database. The differentially expressed genes were identified to screen out the potential biomarkers by use of the GCBI platform. GO and KEGG pathways enrichment analysis were performed to integrate enrichment results of differentially expressed genes. Signal-signal interaction network was constructed and analyzed to screen out potential main downstream pathways.
Results:A total of 1079 differentially expressed genes were screened, including 657 up-regulated and 422 down-regulated ones. Among these genes, REG4 had the maximum fold change value of -6.029 491. In GO term, these differentially expressed genes were mainly enriched in molecule metabolic process, cell cycle, DNA-dependent transcription, signal transduction and apoptotic process. The KEGG pathways enrichment analysis showed that the differentially expressed genes were enriched in 65 KEGG pathways, including metabolic pathways, cell cycle and metabolism pathways. Signal-signal interaction network analysis showed that MAPK signaling pathway and cell cycle pathway might play a determinant role in the development of neoadjuvant chemoradiotherapy resistance. Further analysis showed that CDKN1B, CDKN2A, RBL1, TFDP1, CCND2, CCNE2, CDC6 and CDK6 in cell cycle might induce chemoradiotherapy resistance by blocking G1/S phase cell cycle arrest, decreasing the apoptosis of tumor cells and increasing S phase ratio of chemoradiotherapy resistance.
Conclusion:G1/S phase cell cycle arrest blocking plays an important role in the development of chemoradiotherapy resistance in patients with rectal cancer. Moreover, the key genes, such as REG4, may be useful in predicting responses to neoadjuvant chemoradiotherapy.
